Longevity and Anti-Senescence Therapy Market, 2023 - Emphasis on Stem Cell Research and Increasing demand for Cell-Based Assays

News provided by

May 30, 2019, 17:45 ET

DUBLIN, May 30, 2019 /PRNewswire/ -- The "Global Longevity and Anti-Senescence Therapy Market" report has been added to ResearchAndMarkets.com's offering.

Global longevity and anti-senescence therapy market deals in the adoption of different therapies and treatment options used to extend human longevity and lifespan. Human longevity is typically used to describe the length of an individual's lifetime and is sometimes used as a synonym for life expectancy in the demography. Anti-senescence is the process by which cells stop dividing irreversibly and enter a stage of permanent growth arrest, eliminating cell death. Anti-senescence therapy is used in the treatment of senescence induced through unrepaired DNA damage or other cellular stresses.

Global longevity and anti-senescence market will witness rapid growth over the forecast period (2018-2023) owing to an increasing emphasis on Stem Cell Research and increasing demand for cell-based assays in research and development.

An increasing geriatric population across the globe and rising awareness of antiaging products among generation Y and later generations are the major factors expected to promote the growth of global longevity and anti-senescence market. Factors such as a surging level of disposable income and increasing advancements in anti-senescence technologies are also providing traction to the global longevity and anti-senescence market growth over the forecast period (2018-2023).

Senolytics, placenta stem cells and blood transfusions are some of the hot technologies picking up pace in the longevity and anti-anti-senescence market. Companies and start-ups across the globe such as Unity Biotechnology, Human Longevity Inc., Calico Life Sciences, Acorda Therapeutics, etc. are working extensively in this field for the extension of human longevity by focusing on the study of genomics, microbiome, bioinformatics, and stem cell therapies, etc. These factors are poised to drive market growth over the forecast period.

The report provides analysis based on each market segment including therapies and application. The therapies segment is further sub-segmented into Senolytic drug therapy, Gene therapy, Immunotherapy, and Others. Senolytic drug therapy held the largest market revenue share in 2017. The fastest growth of the gene therapy segment is due to the Large investments in genomics.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Introduction
Drugs, Devices and Technologies Used in the Longevity and Anti-senescence Market
Market Evolution and Key Future Trends
Timeline of Longevity and Anti-senescence
Key Future Trends
Clinical Trials and the Expected Launch of Anti-senescence Products
Standards and Regulations in the Market
United States
European Union
Japan
India
Brazil
Industry Growth Drivers
Increasing Geriatric Population Across the Globe
Surging Level of Disposable Income
Rising Awareness of Anti-Aging Products Among Generation Y and Later Generations
Increasing Advancements in Anti-senescence Technologies

Chapter 4 Global Longevity and Anti-senescence Market by Therapy

Senolytic Drug Therapy
Gene Therapy
Immunotherapy
Others

Chapter 5 Global Longevity and Anti-senescence Market by Application

Longevity
Senescence Inhibition
Cardiovascular Diseases
Neural Degenerative Diseases
Ophthalmology Disorders
Cancer

Chapter 6 Global Longevity and Anti-senescence Market by Region

North America
United States
Canada
Europe
United Kingdom
France
Germany
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Rest of World
Latin America
Middle East and Africa

Chapter 7 Industry Structure in Longevity and Anti-senescence Market

Industry Structure
Suppliers
Research and Development
Manufacturing/Production
Distribution and Marketing
End Users
Investments and Funding Analysis

Chapter 8 Company Profiles

Acorda Therapeutics
Agex Therapeutics
Antoxerene
Calico Life Sciences
Celgene
Cleara Biotech
Cohbar
Human Longevity Inc.
Insilico Medicine
Oisin Biotechnology
Powervision Inc.
Prana Biotechnology Ltd.
Proteostasis Therapeutics Inc.
Recursion Pharmaceuticals
Restorbio
Sierra Sciences Llc
Senex Biotechnology
Senolytic Therapeutics
Spotlight Bioscience
T.A. Sciences
Unity Biotechnology

For more information about this report visit https://www.researchandmarkets.com/r/ovrplo

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets